OVERVIEW
DOCUMENTS/REFERENCES
Biological Information
Background Information:
This assay is intended to assess if a test compound is a substrate for the CYP2C9 enzyme. The stability of the test compound is determined by LCMS after incubation of the test compound with recombinant human CYP2C9
Family:
CYP450
Sub Family:
CYP2
Protein Name:
CYP2C9
Uniprot Number:
P11712
Gene Name:
CYP2C9
Gene ID:
1559
Gene Aliases:
P450IIC9
Organism:
Human
Construct Details:
Full length, recombi
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Detection Method:
HPLC-MS/MS
Measured Response:
Peak Area Response
Testing Information
Substrate:
Test Compound
Incubation:
15 min pre-incubation and 0, 15, 30, 60, and 90 min with NADPH at 37°C
Test Sample Requirements:
Minimum for 1) Screen: 100 μl of 10 mM stock -OR- 1 to 2 mg (pre-weighed). 2) Dose Response: 250 μl of 10 mM stock -OR- 1.5 to 2 mg (pre-weighed).
Turnaround Time
Standard:
15 Business Days
Additional Information
Brand:
Cerep
Testing Location:
USA - St Charles, MO
RELATED SOLUTIONS
CYP2C9 inhibition (recombinant, MFC substrate) - US
Item: 412
CYP2C9 inhibition (HLM, diclofenac substrate) - US
Item: 2066
CYP2C9 inhibition (recombinant, diclofenac substrate) - US
Item: 2067
Time-dependent CYP2C9 inhibition (HLM, diclofenac substrate + NADPH) - US
Item: 2544
Time-dependent CYP2C9 inhibition (HLM, diclofenac substrate - NADPH) - US
Item: 2545
Time-dependent CYP2C9 Inhibition (HLM; diclofenac substrate) - US
Item: G199
CYP Phenotyping - US
Item: G230
Questions? Contact Us
You can easily get in touch with a Eurofins Discovery Expert or get help from our Customer Service team. Reach out with questions, or to discuss your specific discovery challenges.
